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The purpose of the study was to examine the test-retest reliability of the Western Aphasia 
Battery-Revised (WAB-R). Ten people with stroke-induced aphasia were administered the entire 
WAB-R twice. Correlation coefficients were > .80 for 11/13 WAB-R sections/subtests.  Paired t-
tests revealed no significant difference between the means at Time 1 and Time 2 for any of the 
13 WAB-R sections/subtests.  Effect size was less than small for 11/13 WAB-R sections/subtests 
and small for two subtests.  For 8/13 sections/subtests, one WAB-R standard error of 
measurement (SEM) represented less than 5% of the total number of points possible; thus, 68% 
of the time, persons with aphasia would be expected to score within 5% of the total number of 
points possible on repeated testing.  For 5/13 sections/subtests, one WAB-R SEM represented 
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Chapter 1: Introduction 
Standardized aphasia tests serve an important role in both research and clinical practice 
by providing an empirical component to evaluation. The primary metrics of psychometric quality 
for standardized assessment tools, including those specific to aphasia evaluation, are reliability 
and validity. Validity refers to the property of an instrument to measure its target. Reliability 
refers to the instrument’s ability to consistently reproduce a result. More specifically, the several 
components of reliability (e.g., inter-rater reliability, test-retest reliability, internal consistency, 
etc.) concern the extent to which an experiment, test, or measuring procedure yields the same 
results on repeated trials.  
“Test-retest reliability is a statistical technique used to estimate components of 
measurement error by repeating the measurement process on the same participants, under 
conditions as similar as possible, and comparing the observations” (Lavrakas, 2008, pg. 888). 
The data derived from a test-retest study offer information about changes (or a lack thereof) in 
outcomes that can be attributed to genuine change (or genuine stability) over time. A test that is 
dependable and consistently demonstrates good reproducibility allows researchers and clinicians 
to make more informed decisions.  Good test-retest reliability allows examiners to deduce that 
the differences observed are a product of real change and not an artifact of the instrument’s 
instability (Aldridge, Dovey, & Wade, 2017). Thus, the purpose of reliability studies is to 
determine the extent to which repeated measurements yield the same results, when the variables 
(e.g., time, rater, environment, etc.) remain the same (Aldridge et al.; Carmines & Zeller, 1979).  
There are different methods of analyzing reliability and more specifically, score stability. 
Even so, researchers can misinterpret the results of certain statistical measures (Aldridge et al., 





correlation between measurements equates to agreement between those measures (Aldridge et 
al.). It is common to see test-retest reliability assessed using bivariate correlation and tests of 
mean difference (e.g., paired t-tests) (Aldridge et al.).  Here, it is important to make the 
distinction between tests that measure relative standing, and those that measure true stability. 
Neither of the aforementioned analyses are able to appropriately quantify the equality/similarity 
of repeated scores (agreement-based reliability) (Aldridge et al.). The parametric correlation 
coefficients frequently presented in reliability studies (e.g., Pearson’s product-moment 
correlations), use a one-to-one coefficient to quantify consistency in a variable- to measure how 
one variable increases/decreases in relation to the increasing/decreasing of another variable 
(Aldridge et al.).  However, this form of analysis is biased against the magnitude of the variable 
being compared, meaning the calculation is done without consideration of the magnitude. For 
test-retest reliability, this means that differences in value that are a result of intra- and inter-rater 
inconsistency are not detected if the differences are consistent in a sample. In clinical practice 
this would mean that if two patients achieved individual scores of 5/10 and 1/10 on an aphasia 
subtest, and two weeks later (without any change in their conditions) those same two patients 
achieve scores of 8/10 and 4/10, respectively, then a parametric correlation coefficient would 
yield a high level of statistical significance and suggest reproducibility. However, the raw data in 
the example show that there is some inconsistency undetected by the analysis (be it intra-rater 
reliability or test-retest reliability). Tests of mean difference are also subject to bias and 
secondary misinterpretation. Examining only the group average on a performance test can 
generate bias against individual score change. For example, on the first testing date, Subject A 
scores 100/100 on the exam and Subject B scores 50/100 (x̅ = 50), then on the second testing 





two scores is the same, a test of mean difference would show high congruency. A researcher 
might misinterpret the lack of difference between the two averages as score stability. However, 
neither bivariate correlation nor tests of mean difference are measures of true score stability. 
Therefore, these tests do not yield the information most appropriate for determining test-retest 
reliability.  
To obtain a representative measurement of score stability, researchers have employed the 
standard error of measurement (SEM) as a method of analysis coupled with a percentage change 
score (Beckerman et al., 2001; Flanagan & Jackson, 1997). The SEM generates an estimated 
range of future performance scores. A single true score cannot be produced, due to the random 
error present in all standardized aphasia tests. A reliable test is one that minimizes random error. 
Researchers are able to deduce test-retest reliability between test scores by figuring the 
variability in measurements of the same participant; a small SEM range would suggest that an 
unchanged subject will score similarly on all administrations of the same test. SEM is calculated 
using the following equation: 
SEM = SD√1-r 
where SD is the standard deviation of the scores from testing date 1 and r is the correlation 
between the testing date 1 and 2 scores using Spearman's rho as the measure of correlation. The 
SEM allows researchers to predict future performance scores based on an observed score. The 
chances that a predicted performance score will not differ from the obtained performance score 
by more than ±1 SEM is 68 in 100. For example, Subject A scores a 10/20 on an exam whose 
SEM is 3. If Subject A were to be administered the exam 100 times, we would expect that in 68 
of those instances, the subject would score within a range of ±1 SEM (in this example: 7/20 to 





performance score by more than ±2 SEM is 95 in 100.  Using the same subject, test, and number 
of trials from the above example, we would expect that in 95 of those instances, the subject 
would score within a range of ±2 SEM (in this example: 4/20 to 16/20). Typically, the smaller 
the SEM, the greater the test-retest reliability (Nicholas & Brookshire).  A “good” SEM value 
depends on the magnitude of the scores that can be expected. “For example, a SEM of 10 would 
be acceptable if the scores ranged from 100 to 500, but a SEM of 10 would not be acceptable if 
the range of scores was 0 to 20” (Nicholas & Brookshire, pg. 405). However, SEM ranges alone 
do not provide a straightforward measure of test-retest reliability, due to the varying significance 
of the actual numerical value (Nicholas & Brookshire). For example, a difference of one point on 
a 60-point test can contribute to the distinction between two clinical diagnoses.  Thus, without 
knowledge of the overall context /numerical value of the test, the range established using the 
SEM lacks purport. Historically, a percentage change score (PC) has been used in conjunction 
with the SEM to determine if the range generated by the SEM is significant or would make any 
clinical distinction (Flanagan & Jackson, 1997; Nicholas & Brookshire). PC is calculated using 
the following equation: 
PC = (SEM/Number of Items) x 100 
"’where PC represents the percentage change from the [number of test items] accounted for by a 
change in score of 1 SEM between sessions’ (Nicholas & Brookshire, p. 342), and Number of 
Items represents the number of items in a particular test” (Flanagan & Jackson, pg. 38). The PC 
makes clear the value of the SEM as it pertains to the total number of test items. For example, 
the SEM calculated for the Boston Naming Test (BNT) (Kaplan, Goodglass, & Weintraub, 
1983), which has 60 items, was 1.02 and the PC calculated was 1.70 (Flanagan & Jackson). 





of 48.98 to 51.02 (±1 SEM), in 68% of all instances. The BNT’s SEM indicates that a subject 
will score similarly on future administrations of the test (provided both the test and the subject 
are unchanged). The percent change analysis reveals that one SEM represents 1.70% of the total 
number of items within the BNT, suggesting that changes attributed to random error would likely 
not influence the overall impressions of test performance. The combination of the SEM analysis 
and PC score yield a value of test-retest reliability not offered by bivariate correlation and tests 






Chapter 2: Review of the Literature 
For the Western Aphasia Battery-Revised (WAB-R) (Kertesz, 2007), neither the SEM 
and PC, nor any other statistical analysis was performed to examine test-retest reliability. Several 
years after the original Western Aphasia Battery (WAB) (Kertesz, 1982) was published, the 
updated version was released (Kertesz, 2007). The revised assessment includes the following 
changes: the introduction of new subtests (Supplemental Reading and Supplemental Writing), 
changes made in directions to examinees in the Spontaneous Speech section, new verbal and 
visual stimuli in the Object Naming subtest, new verbal stimuli and rearrangement of item order 
in the Repetition subtest, a new verbal stimulus in the Apraxia subtest, and added task 
instructions to the Clock Drawing portion of the Drawing subtest (Kertesz, 2007). Along with the 
omissions, additions, and revisions listed above, a new analysis of language scores, the 
“Language Quotient”, was added. This additional component to scoring was made to allow the 
examiner to characterize language function with consideration of reading and writing abilities, 
using a quantitative score. While the WAB (Kertesz, 1982) has undergone extensive 
standardization testing, the psychometric soundness of the revised version remains relatively 
unknown. More specifically, the ability of the WAB-R (Kertesz, 2007) to detect the same 
deficits in the same person following a secondary administration (provided there is no change in 
the disability), is comparatively unidentified, when considering the original version.  
The Western Aphasia Battery (WAB) (Kertesz, 1982) is a standardized assessment used 
typically to assess cognitive-linguistic skills in adults with acquired neurological disorders (e.g., 
post-stroke aphasia). The WAB (Kertesz, 1982) is comprised of various subtests (i.e., word 
fluency, object naming, etc.) that target areas of cognitive-linguistic communication commonly 





aphasia who were one or more years post-onset were tested and retested using the WAB 
(Kertesz, 1979; Kertesz, 1982). From here on, this study will be referred to as Study 1. No 
information about the time between testing dates is made clear by the author, nor is this 
information present in the manual. The researcher did, however, report that no significant 
medical changes took place between the two testing times (Kertesz, 1979). Kertesz (1979) 
reported a Pearson’s r correlation coefficient of 0.992 and used the statistical significance (p < 
0.01) as evidence of a lack of significant medical change and high test-retest reliability. Kertesz 
(1979) goes on to offer additional support in the form of a low mean difference (0.9) between 
test scores and retest scores. It was not stated which scores were used to calculate the Pearson’s r 
correlation coefficient or the mean difference (e.g., Aphasia Quotient, Cortical Quotient, specific 
subtest scores, etc.). In addition to the lack of performance data, the quality and significance of 
this evidence is further called into question because no demographic data (e.g., age, type/severity 
of aphasia, etc.) is available for this initial sample population. Consequently, clinicians 
administering the WAB (Kertesz, 1982) in practice are unable to validate the test-retest 
reliability using information found in this study. 
The WAB (Kertesz, 1982) underwent a second examination of test-retest reliability 
which from here on will be referred to as Study 2. A second group of participants (N=35) with 
(stable) chronic aphasia were administered the assessment on two different testing dates 
(Kertesz, 1979).  “The mean post onset time of the first test was 2.05 years and the second, 3.91 
years” (Kertesz 1979, pg. 70). A paired t-test also was conducted to compare mean scores of test 
performance to retest performance on all subtests.  The mean Aphasia Quotient and Cortical 
Quotient scores (achieved on the test and the retest) were also compared. There was no 





statistically significant differences were observed on the Word Fluency subtest, Object Naming 
subtest, and the overall naming total. “Slightly significant” differences were observed on the 
Reading and Writing sections (Kertesz, 1979). Neither of the analyses used in Study 2 were able 
to capture a measurement of score stability because of the measures used to assess the data. 
Further, the differences that were observed, though statistically significant, were discussed 
without detail; therefore, no conclusions can be made about the lack of statistical significance 
observed in some subtests. The test-retest reliability data points of Study 2 are presented in Table 
1. 
Section 
Means Pearson’s r 
1st Test 2nd Test N-pairs (Test 1-2) 
Information Content 5.00 5.20 35 0.95 
Fluency 5.45 5.28 35 0.93 
Yes/No Questions 47.57 49.62 35 0.75 
Auditory Word Recognition 41.11 40.51 35 0.85 
Sequential Commands 51.08 49.20 35 0.90 
Comprehension Total 7.05 6.97 35 0.88 
Repetition 5.57 5.35 35 0.97 
Object Naming 30.02 33.25 35 0.94 
Word Fluency 5.11 6.28 35 0.89 
Sentence Completion 6.17 5.94 35 0.88 
Responsive Speech 5.48 5.60 35 0.96 
Naming Total 4.67 5.12 35 0.96 
Aphasia Quotient 55.36 55.48 35 0.97 
Reading 63.30 63.30 30 0.92 
Writing 53.37 57.22 24 0.95 
Praxis 78.29 78.11 17 0.45 
Drawing 16.64 17.20 25 0.79 
Block Design 7.20 7.26 15 0.89 
Calculation 17.58 18.00 24 0.81 
Raven’s Coloured Progressive 
Matrices 
21.61 22.19 26 0.89 






The WAB’s test-retest reliability was again examined in a study that will be referred to as 
Study 3 (Shewan & Kertesz, 1980). A sample group of participants (N=38) with (stable) chronic 
aphasia were administered the assessment on two different testing dates (Shewan & Kertesz). 
The time between tests varied from six months to six years, six months (Shewan & Kertesz).  
The considerable length of time between testing dates calls into question the overall stability of 
the participants related to or notwithstanding the language disorder. Further, Shewan and Kertesz 
stated that the same examiner did not always administer the test on both occasions during the 
study. Shewan and Kertesz acknowledged their lack of control for ‘Examiner’ as a variable 
reporting that, “the interrater differences may have affected the results of temporal stability”. 
However, the researchers reported no significant differences in performance on the majority of 
the WAB (Kertesz, 1982) subtests, suggesting reproducibility of results (Shewan & Kertesz).  A 
Pearson’s product-moment correlation coefficient was used to support the above conclusion. All 
correlations were greater than 0.880 and were significant at the 0.001 level, with the exception of 
the Praxis subtest (Pearson’s r = 0.581; significance= 0.006) (Shewan & Kertesz). No further 
detail was given about the lack of reproducibility observed within the Praxis subtest. Moreover, 
it is apparent from the data reported in Study 3 that all participants were not included in the 
analysis. Table 2 presents the test-retest reliability data points of Study 3, and also demonstrates 
that some participants were excluded from the analysis of the Reading, Writing, Praxis, and 









WAB Variable Number of subjects Pearson’s r Significance Level 
Information Content 38 0.947 0.001 
Fluency 38 0.941 0.001 
Comprehension Total 38 0.881 0.001 
Repetition 38 0.970 0.001 
Naming Total 38 0.923 0.001 
Aphasia Quotient 38 0.968 0.001 
Reading 32 0.927 0.001 
Writing 25 0.956 0.001 
Praxis 18 0.581 0.006 
Construction 14 0.974 0.001 
Cortical Quotient 9 0.895 0.001 
    Table 2. Correlation coefficients for test-retest reliability for WAB variables (Shewan & Kertesz, 1980) 
 
A novel examination of the test-retest reliability of the WAB-R is necessary given that 
the information and data provided in the manual are not representative nor applicable to the 






Chapter 3: Methods 
Participants 
Fourteen persons with stroke-induced aphasia were consented, and 10 of these 
individuals completed the study. The participants were recruited from previous studies conducted 
by Susan Jackson, from the American Stroke Foundation, hospitals, outpatient clinics, and 
aphasia treatment groups in the Kansas-Missouri bi-state area. All participants were monolingual 
English speakers who were literate prior to their stroke (per self-report) with adequate hearing 
and vision. Adequate hearing was defined as the ability to follow at least 4/5 one-step directions 
presented auditorily (see Appendix A). Adequate vision was defined as at least 4/5 accuracy on a 
simple and brief picture-matching task. The vision screening procedure included five picture 
sets, each containing four black and white line drawings. Vision screening accuracy was 
determined by the participants’ ability to match a target stimulus to its replica in the stimulus set. 
The stimuli within each set (and the target stimulus) are listed in Appendix B. Participants who 
passed the screening using hearing or vision aids were required to wear/use the respective aids 
during all interviews and testing. Participants were excluded from the study if they presented 
with a history of additional neurological disease (e.g., traumatic brain injury). Participants also 
were excluded if they did not score within the aphasic range on the WAB-R (Kertesz, 2007), 
which is defined as an Aphasia Quotient of 93.8 or above. Four individuals were excluded from 
the study. Three individuals were excluded from the study based on their mild presentation of 
aphasia, and one person was excluded because he had a traumatic brain injury in addition to a 
stroke.  
All participants included in the study were at least six months post-onset of a left-





Months post onset of stroke varied from 8 months to 234 months (M = 65, SD =68). Years of 
education ranged from 12 years to 21 years (M = 16, SD =3). Each participant’s race/ethnicity, 
gender, pre-morbid handedness, and occupation also were recorded. Table 3 presents the 
demographic information in greater detail. Additional demographic information collected from 
each participant included a current list of medications. All demographic data were collected via 
self-report using an aphasia questionnaire created for this study (see Appendix C). Each 















1 67 112 13 B/AA M R None Stocker 
2 36 35 18 W/C F R Group Retired 




4 71 48 18 W/C M R Group and 
Individual 
Teacher 
5 69 234 21 W/C M R Group Retired 
6 72 24 21 W/C M R Group Judge 
7 76 23 12 W/C M R Group and 
Individual 
Oil Digger 
8 69 8 18 W/C M R Individual Retired 
9 75 100 16 W/C M R Group and 
Individual 
Teacher 




  Table 3. Demographic data. M = Male, B/AA = Black/ African-American, W/C = White/ Caucasian, R = Right,  
  L = left 
 
Stimuli 
 Test items from Part 1 and Part 2 of the Western Aphasia Battery-Revised (WAB-R) 
(Kertesz, 2007) constituted the stimuli; the test assessed speech content, fluency, auditory 





apraxia. The Raven’s Coloured Progressive Matrices (Raven, 1976) also were included as part of 
Part 2 of the WAB-R.  
Procedure 
Researchers first obtained approval for conducting the study from the University of 
Kansas Medical Center Institutional Review Board. Informed consent was obtained before 
testing began. Consent to participate in the study was acknowledged by signing a written consent 
form (see Appendix E). All participants signed their own consent. A surrogate consent form was 
available for participants who were unable to provide their own written consent due to language 
comprehension difficulty (see Appendix F), with an accompanying assent form (see Appendix 
G), but these additional consent forms were not needed. After providing consent, participating 
participants were assigned a number code to replace identifying information and preserve 
confidentiality (e.g., WAB-1, WAB-2, etc.). Each participant was then administered a 
questionnaire (see Appendix C) to collect demographic information and identify clinical 
characteristics incompatible with the study. Participants were then screened for adequate hearing 
and vision, as described above. Next, all sections and subtests of the Western Aphasia Battery-
Revised (WAB-R) (Kertesz, 2007) were administered.  The WAB-R was presented to all 
participants in the same order, with the exception of Participant 5 who was not administered the 
Block Design subtest, and Participant 10 who elected to discontinue the administration of the 
Apraxia and the Constructional, Visuospatial, and Calculation portions of the WAB-R. The 
examiners adhered to the administration and scoring procedures stated in the test manual. After a 
2-week interval, participants were briefly interviewed about changes in medication (including 
dosage) and health status during the interval period, and then underwent a second administration 





place during the interval period, with the exception of Participant 3 who discontinued one of his 
medications. Testing and retesting took place in the participants’ homes, at the Schiefelbusch 
Speech and Hearing Clinic, and in the Department of Hearing and Speech at the University of 
Kansas Medical Center. Participants were tested by one of three graduate student clinicians (BB, 
HH, AE). BB tested Participants 1, 3, 4, 7, W-1 (withdrawn), W-2 (withdrawn), W-3 
(withdrawn), W-4 (withdrawn), 9, and 10.  AE tested Participant 6, and HH tested Participants 2, 
5, and 8. All participants were assessed by their same examiner at Time 1 and Time 2. All 







Chapter 4: Results 
Individual Data 
The individual data are presented in Appendix H. 
Data Analyses 
 Some of the data analyses were completed using the IBM SPSS Statistics software 
package (Pearson Product-Moment correlation, paired t-test). Other analyses were done by hand 
(SEM and Percent Change score). The effect size was calculated using an online calculator for 
Cohen’s d (https://www.socscistatistics.com/effectsize/default3.aspx). The data consisted of the 
total number of points achieved on each section or subtest of the WAB-R (Kertesz, 2007). The 
WAB-R (Kertesz) typically divides the raw score by 10 or 20, to calculate quotient scores 
(Aphasia Quotient, Language Quotient, and Cortical Quotient). However, to preserve 
information about changes in performance, the current study used the raw scores instead of the 
adjusted scores generated by the WAB-R (Kertesz). Each analysis was performed on the data 
from all 10 participants with the exception of the Constructional, Visuospatial, and Calculation 
section and the Cortical Quotient, which included eight participants in the analysis because 
Participant 5 was not administered the Block Design subtest and Participant 10 elected to 
discontinue the Constructional, Visuospatial, and Calculation portions of the test. Analysis of the 
Apraxia subtest data included nine participants, as Participant 10 elected to discontinue this 
subtest as well. 
 
Pearson Product-Moment Correlation  
The purpose of performing the Product-Moment Correlational analysis was to compare 
the data from the current study to prior results of WAB (Kertesz, 1982) score stability, which 





correlation coefficients for the relation between the participants’ WAB-R performance at Time 1 
and Time 2.  
WAB-R Sections/ Subtests 
Pearson’s r  
(Time 1-Time 2) 
p-value 
Aphasia Quotient .973 .0001 
Language Quotient .940 .0001 
Cortical Quotient .915 .001 
Spontaneous Speech  .866 .001 
Auditory Verbal Comprehension  .151 .678 
Repetition  .980 .0001 
Naming  .993 .0001 
Reading .910 .0001 
Writing .897 .0001 
Apraxia .631 .069 
Constructional, Visuospatial, and Calculation .925 .001 
Supplemental Reading .842 .002 
Supplemental Writing .874 .001 
Table 4. WAB-R Pearson’s Product-Moment coefficients and p-values 
 
 
The overall α was chosen as .05. The overall α was then divided by the number of analyses (13), 
which resulted in an α level of .0038 for each individual correlational analysis. Results indicated 
a positive, significant correlation between the test date (T1) and retest date (T2) for scores 
achieved on all subtests and sections except the Auditory Verbal Comprehension section and the 
Apraxia subtest.  
 
Paired t-test and Effect Size 
Although the paired t-test is not a valid measure of score stability, this statistical analysis 
was performed to compare the data from the current study to the results of previous studies 
examining the test-retest reliability of the WAB (Kertesz, 1982). Table 5 displays the results of a 





significant difference in mean performance was defined as any value of p that was less than α (α 
= .0038; overall α = .05/13 [number of t-tests]).  





1st Test  2nd Test  
Aphasia Quotient 71.02 (16.16) 70.49 (17.39) .689 0.032 
Language Quotient 69.07 (14.63) 68.43 (15.18)  .705 0.043 
Cortical Quotient 73.42 (11.58) 74.17 (11.73) .674 0.064 
Spontaneous Speech  14.50 (3.06) 14.00 (3.55) .397 0.151 
Auditory Verbal 
Comprehension  
173.00 (18.69) 174.90 (14.68)  .791 0.113 
Repetition  61.90 (24.35) 61.30 (26.28) .735 0.024 
Naming  61.70 (30.34) 63.70 (30.64) .125 0.066 
Reading 72.40 (20.80) 69.70 (20.02) .352 0.132 
Writing 55.50 (23.94) 54.55 (21.14) .783 0.042 
Apraxia 55.20 (4.17) 56.22 (3.41) .384 0.268* 
Constructional, Visuospatial 
and Calculation 
69.37 (15.74) 71.81 (14.85) .288 0.159 
Supplemental Reading 7.4 (4.81) 8.00 (5.29) .526 .119 
Supplemental Writing 2.00 (2.66) 3.50 (3.71)  .034 .465* 
    Table 5. WAB-R paired t-test and effect size. * = Small effect size 
 
There were no statistically significant differences in the mean scores from Time 1 to Time 2. 
Calculation of effect size was undertaken to examine at the magnitude of mean differences. 
Effect size is less susceptible to the fluctuations that arise due to a small number of participants, 
as in the current study. Effect sizes are presented in Table 5. The effect size was calculated using 














where M1 is the mean at Time 1, M2 is the mean at Time 2, SD1 is the standard deviation at Time 
1 and SD2 is the standard deviation at Time 2. Results were designated as having less than a 
small effect (d < 0.2), a small effect (d = 0.2-0.49), a medium effect (d = 0.5-0.79), or a large 
effect (d > 0.8), as recommended by Cohen (2013). There was a small effect size for the Apraxia 
subtest and the Supplemental Writing subtest. The remaining sections/subtests showed less than 
a small effect size. 
 
Standard Error of Measurement and Percent Change Score 
  As previously mentioned, the SEM provides limited information about test-retest 
reliability when examined in isolation; thus, the Percent Change score was calculated to 
supplement the SEM by adding information about the number of points on each WAB-R 
(Kertesz, 2007) section or subtest. Standard error of measurement was calculated using the 
following formula: 
SEM = SD√1- r 
The outcome of the analysis was a number used to establish a range of future 
performance scores based on the observed score (±1 SEM = 68% confidence interval; ±2 SEM = 
95% confidence interval). If a standardized assessment is stable, an examiner can expect a small 
range of future performance scores in an unchanged individual, otherwise stated as a confidence 
interval with minimal variability. In this way, standard error of measurement quantifies the 
amount of random error variability in the test, allowing the examiner to predict the impact of 
random error on the examinee’s true performance score. Table 6 displays the SEMs of the WAB-
R (Kertesz, 2007) sections and subtests. The Percent Change scores (PCs) also are presented in 
Table 6.  While it has been convention to calculate the SEM using the total number of items in a 





(Spontaneous Speech) and some sections have greater than 50 (Auditory Verbal 
Comprehension). Further, points are distributed unevenly across sections, and weighted 
differently within subtests. Consequently, a Percent Change score calculated using number of 
items within a WAB-R section/subtest would not be as meaningful as a score based on the 
number of points. Thus, the Percent Change score was calculated using the following equation: 
PC = (SEM/Number of Points Possible) x 100 
The Percent Change score takes into account the total number of points possible when 
interpreting the SEM. For example, an SEM of 2 points indicates that 68% of the time, a person 
will score ±2 points of his/her initial score on repeated testing. The PC indicates that 2 points is 
2% of the overall number of points possible if 100 points are possible, and 2 points is 20% of the 
overall number of points possible if 10 points are possible. 
WAB-R Sections/ Subtests 
Standard Error of 
Measurement 
Percent Change score 
Aphasia Quotient (Max= 100) 2.65 2.65 
Language Quotient (Max= 100) 3.58 3.58 
Cortical Quotient (Max= 100) 3.37 3.37 
Spontaneous Speech (Max= 20) 1.12 5.60* 
Auditory Verbal Comprehension (Max= 200) 17.22 8.61* 
Repetition (Max= 100) 3.44 3.44 
Naming (Max= 100) 2.53 2.53 
Reading (Max= 100) 6.24 6.24* 
Writing (Max= 100) 7.68 7.68* 
Apraxia (Max= 60) 2.53 4.21 
Constructional-Visuospatial, Calculation (Max= 100) 4.31 4.31 
Supplemental Reading (Max= 20) 1.91 9.56* 
Supplemental Writing (Max= 20) 0.94 4.73 
Table 6. WAB-R Standard Error of Measurement and Percent Change score. * = greater than 5 
 
The PCs that were calculated ranged from 2.65 to 9.56. This means that one WAB-R 





sections and subtests of the WAB-R (Kertesz, 2007). Examples will be provided to further 
explain the interpretation. The first example uses the Aphasia Quotient Percent Change score. 
The Aphasia Quotient PC was 2.65; thus, 1 SEM represents 2.65% of the total number of points 
possible for an Aphasia Quotient. Restated, 68% of the time, an examinee will score ±2.65 % of 
the total number of points possible for the Aphasia Quotient on repeated testing. The second 
example uses the Supplemental Reading subtest Percent Change score. The Supplemental 
Reading subtest PC was 9.56; therefore, 1 SEM represents 9.56% of the total number of points 
possible for the Supplemental Reading subtest. Accordingly, 68% of the time, an examinee will 
score ±9.56% of the total number of points possible for the Supplemental Reading subtest on 
repeated testing.  The majority of the WAB-R (Kertesz, 2007) sections and subtests had PCs that 
were less than 5. This indicates that examinees would be expected to score within ±5% of the 
total number of points possible on repeated testing of the WAB-R sections/subtests, 68% of the 
time. Five of the subtests/sections had PCs greater than 5 but less than 10 (Spontaneous Speech, 







Chapter 5: Discussion 
This study reports the score stability of the WAB-R using 10 participants with chronic 
aphasia who were tested an average of 65 months post-onset of stroke and retested two weeks 
later. The discussion will focus on an interpretation of the results, as well as a comparison 
between the current results and the findings of the original WAB reliability studies. Possible 
explanations will be offered for the differences between the current study and past WAB 
reliability studies. 
The present study employed a Pearson Product-Moment Correlation analysis and a paired 
t-test analysis as measures of statistical significance. Statistical significance refers to any 
considerable differences observed, according to the standard logic and procedures of inferential 
statistics (Bothe & Richardson, 2011). Previous studies (Kertesz, 1979) also have implemented 
these analyses to assess the reliability of the WAB. However, as mentioned previously, neither 
correlational analyses nor t-tests are appropriate measures of score stability. That being said, the 
correlation coefficients ranged from .151 to .993 for the 13 sections/subtests of the WAB-R, with 
only two sections/subtests falling below .80 (Auditory Verbal Comprehension section and 
Apraxia subtest). It is difficult to compare the results of the correlational analyses from the 
current study to the results of the correlational analyses from two previous studies. Kertesz 
(1979), Kertesz and Shewan (1980), and the current study have seven sections/subtests in 
common for the correlational analyses. Kertesz and Shewan (1980) have one additional 
WAB/WAB-R section in common with the correlational analyses of the current study (Cortical 
Quotient). Thus, not all of the current correlation coefficients can be compared to correlation 
coefficients from previous studies. Four of the coefficients from the previous studies were based 





Comprehension: 200 (current study) vs. 10 (Kertesz), Repetition: 100 (current study) vs. 10 
(Kertesz), Naming total: 100 (current study) vs. 10 (Kertesz), and Apraxia/ Praxis: 60 (current 
study) vs. 100 (Kertesz)]. The current study used the raw data scores for the correlational 
analyses, whereas the previous reliability study (Kertesz, 1979) divided the raw score by 10 or 
20 before performing the correlational analyses. It was not possible to determine the denominator 
of the scores used in the Kertesz and Shewan (1980) correlational analyses. A comparison of the 
data is presented in Table 7. 
WAB/ WAB-R 
Section/Subtest 
Current Study Kertesz (1979) Kertesz & Shewan 
(1980) 
Aphasia Quotient .973 .97 .968 




.151 .88 .881 
Repetition* .980 .97 .970 
Naming/ Naming Total* .993 .96 .923 
Reading .910 .92 .927 
Writing .897 .95 .956 
Apraxia/ Praxis* .631 .451 .581 
Table 7. Coefficient comparison. * = different denominators across studies 
 
Given the challenges of comparing the correlation coefficients from the current study 
with correlations from previous studies, three conclusions can be reached: 1) correlation 
coefficients are predominately above .85 across all three studies, 2) the Praxis/Apraxia 
correlation coefficient was the lowest or second lowest across all three studies (.631, .451, and 
.58), and 3) the Auditory Verbal Comprehension correlation coefficient from the current study 
was drastically lower (.151) than the correlation coefficient from the other two studies (.88 and 





Commands) within the Auditory Verbal Comprehension section, and perhaps the combination of 
this outlier and a small sample size conspired to result in a very low correlation coefficient.  
 Using the t-test as the test of statistical significance, the current study found no 
significant difference between the mean scores at Time 1 and Time 2 for any of the 13 WAB-R 
sections/subtests examined. One of the previous studies examining the test-retest reliability of 
the WAB (Kertesz, 1979, Study 1) did not implement a t-test to assess the differences in WAB 
scores at Time 1 and Time 2, but the mean difference between test and re-test scores was 
reported (.9). This number is difficult to interpret given we do not know which WAB scores were 
used to calculate the mean difference (i.e., Aphasia Quotient, Cortical Quotient, specific subtest 
scores). The second of two previous studies examining the test-retest reliability of the WAB 
(Kertesz, 1979, Study 2) did use t-tests in the analysis of test-retest reliability. The current study 
and the Kertesz (1979) Study 2 have seven sections/subtests in common for the t-tests. See Table 
8 for the p-values associated with the current study and the description of whether there was a 
statistically significant difference in the Kertesz (1979) Study 2. Kertesz (1979) Study 2 did not 
provide information about the p-value used to determine whether there was a statistically 
significant difference between the mean scores at Time 1 and Time 2. Further, no definition was 
given for the term “slightly significant.” 
 
WAB/ WAB-R sections/subtests Current Study Kertesz (1979) Study 2 
Aphasia Quotient p > .05 NS 
Auditory Verbal Comprehension/ 
Comprehension Total* 
p > .05 NS 
Repetition* p > .05 NS 
Naming/ Naming Total* p > .05 “Significant” 





Writing p > .05 “Slightly Significant” 
Apraxia/ Praxis* p > .05 NS 
Table 8. Comparison of t-test findings. NS = not significant, * = different denominators across studies 
 
Practical significance refers to the magnitude of any differences observed (Bothe & 
Richardson, 2011) - in this instance, how much change was observed between Time 1 and Time 
2 in WAB-R outcomes. Practical significance is commonly measured using effect size. This 
study adhered to that convention. Two of the 13 WAB-R sections/subtests showed a small effect 
size (Supplemental Writing and Apraxia), and the remaining 11 WAB-R sections/subtests 
showed less than a small effect size, suggesting fair-good score stability.  
Clinical significance refers to change that is meaningful/valuable to the patient and 
clinician in the context of service provision (Bothe & Richardson, 2011). In the present study, 
standard error of measurement (SEM) and Percent Change score were used to measure clinically 
significant changes in scores obtained on initial testing and re-testing of the WAB-R. No studies 
examining score stability of the WAB (Kertesz, 1982) have used the SEM or Percent Change 
score to determine test-retest reliability. Percent Change score is preferred over SEM as a 
measure of score stability because it accounts for the magnitude of the scores on which the SEM 
is based. The Percent Change score “represents the percentage change from the [the number of 
points] accounted for by a change in score of 1 SEM between sessions” (Nicholas & Brookshire, 
1993, p. 342). In the current study, 1 SEM represented between 2.65% and 9.56% of the total 
number of points possible on the various sections and subtests of the WAB-R. For 8/13 WAB-R 
sections/subtests, 1 SEM represented less than 5% of the total number of points possible, which 
means that 68% of the time, the score of people with aphasia changes by less than ±5% of the 
total number of points possible, on repeated testing. Currently, there is no consensus on what 





acceptable PC score, including whether a certain magnitude of change on repeated testing would 
result in a different aphasia classification, would result in a different severity of aphasia, or 
would indicate a change in the type of intervention chosen. For 5/13 subtests/sections of the 
WAB-R, 1 SEM represented greater than 5% but less than 10% of the total number of points 
possible: Spontaneous Speech, Auditory Verbal Comprehension, Reading, Writing, and 
Supplemental Reading.  
Higher PC scores might be explained by: 1) the distribution of points within subtests, 2) a 
small number of items within a subtest, or 3) the clinical judgement of new clinicians. Several 
WAB-R subtests and sections have an uneven distribution of points per item, namely the 
Comprehension of Sentences subtest in the Reading section and the Sequential Commands 
subtest of the Auditory Verbal Comprehension section. These subtests allocate small point 
values to some items (i.e., 2/ 80 points) and large point values to other items (i.e., 20/80 points). 
This distribution of points is not conducive to score reproducibility because performance in the 
target language domain is influenced by a single heavily weighted item or a few heavily 
weighted items. Otherwise stated, the examinee need only answer one or two questions on the 
subtest incorrectly for the WAB-R score to plummet. Conversely, if the examinee responds 
correctly to these few items, the WAB-R score soars. As seen in the results of the current study, 
score instability can lead to changes in the level of aphasia severity and/or the classification of 
aphasia type. A small number of items within a subtest also has the potential to affect the test-
retest reliability of a measure. A small number of items on a measure leaves the entire test 
susceptible to change based on a single item, limiting score stability. Consider a 5-point test, 
where each point amounts to 20% of the overall score. A 2-point change in score would have a 





change on a 20-point test would have less of an effect because each point is worth 5% of the 
overall score. 
Lastly, some of the WAB-R sections/subtests with higher PC scores had more subjective 
scoring. Making clinical judgements can be especially challenging for new clinicians who have 
limited experience making these real-time judgements and limited clinical exposure to deficit 
presentations of the language domain being assessed. Thus, it is likely that inexperienced 
clinicians will demonstrate less consistency in making judgements of performance.  
 
Implications 
The absence of WAB-R test-retest reliability data prompted the current study. The 
purpose of this investigation was to determine the extent to which the WAB-R is able to 
accurately reproduce results on two separate occasions. Results of the study suggest that many of 
the components of the test yield score stability. However, clinicians should be aware of the PC 
score results that suggested less score stability in the following sections/subtests: Spontaneous 
Speech, Auditory Verbal Comprehension, Reading, Writing, and Supplemental Reading. 
Instability in the Spontaneous Speech scores or the Auditory Verbal Comprehension scores could 
result in changes in the WAB-R aphasia classification, which is one of the main purposes of an 
impairment level aphasia battery. Instability in the Spontaneous Speech scores or the Auditory 
Verbal Comprehension scores also could result in changes in the severity of aphasia determined 
by the WAB-R. In fact, four of the participants in the current study were assigned a different 
aphasia severity at Time 1 and Time 2, and two participants differed in their aphasia type at Time 







This study was limited by its small sample size. When sample size is small there may not 
be enough power to detect a statistically significant difference had one existed.  Further, the 
small sample was limited in its diversity of race, ethnicity, and gender. One person in the study 
was African-American, and two people in the study were women. These ratios do not accurately 
represent the broader population of individuals with aphasia. Because the individuals in the 
present study are not representative of the population, the generalizability of the results is 
limited. The majority of the participants in the current study had mild to moderate aphasia. One 
of the participants had severe aphasia at Time 1 and moderate aphasia at Time 2, and another 
participant had severe aphasia at both time points. None of the participants had very severe 
aphasia. Thus, the results of this study are not generalizable to people with severe aphasia or very 
severe aphasia.  The study also was limited by access to testing materials. Materials were limited 
to a single copy of the WAB-R, restricting the availability for participant testing. The experience 
level of the examiners was a limitation. Each of the graduate students were relatively new 
clinicians whose emerging clinical judgement presented challenges in the scoring of subjective 
portions of the WAB-R (i.e., Spontaneous Speech and Writing). 
 Future Studies 
Ideally, future studies would include a larger sample size with increased racial, ethnic, 
and gender diversity as well as varying severities of aphasia. In addition to participants with mild 
and moderate aphasia, future studies should include people with severe and very severe aphasia. 
Future studies also might incorporate the use of video recording technology as a way of 
preserving performance data. The WAB-R ascribes a categorization of aphasia type to the 





Verbal Comprehension, Repetition, and Naming). It was observed in the present study that some 
participants were promoted/demoted to a different aphasia type between T1 and T2. Future 
studies are needed to investigate the degree to which scores on testing and re-testing indicate a 
different diagnosis (e.g., aphasic vs. non-aphasic) and/or a different type of aphasia.  Future 
studies also might survey speech-language pathologists to determine what degree of change in 
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Appendix A. (Hearing Screening-Auditory Commands) 
 
Aided Hearing (e.g., personal amplifier, hearing aids, etc.)                    Yes              No 
 
Present each item verbally 
1. Clap your hands       0           1 
2. Touch your head        0           1 
3. Point to your nose       0           1 
4. Stick out your tongue       0           1 
5. Look at the ceiling       0           1 








Appendix B: (Vision Screening-Picture Matching) 
Aided Vision (e.g., glasses, bifocals, contacts, etc.)                    Yes              No 
 
Explain to the participant that they will be shown a single picture and asked to match it to an 
identical picture amongst a set of four picture. Present target stimulus first. Then, present 
stimulus set. 
1. Stimulus Set (example)     0           1 
• Spoon 
• Basketball 
• Elephant (target) 
• Woman 
2. Stimulus Set #1       0           1 
• Gas 
• Cake (target) 
• Towel 
• Chair 
3. Stimulus Set #2       0           1 




4. Stimulus Set #3      0           1 
• Flowers 
• Dog (target) 
• Book 
• Candy 











Appendix B: (Vision Screening-Picture Matching)-continued 
 
6. Stimulus Set #5      0           1 
• Shoes 
• Butterfly 









Appendix C: (Initial Aphasia Questionnaire) 
Participant #: ______________________     
DOB: ______ /______ /______ 
Gender:  Male        Female  
Consent Type:        Consent       Surrogate         Assent 
Race/Ethnicity:      White/ Caucasian  Black/ African-American Native-American  
Hispanic/ Latin-American Asian/ Pacific Islander Other 
Hx of other neurologic disease (e.g., head injury, Parkinson’s, history of alcohol abuse): 
Multiple Strokes:  Yes        No   
Date of stroke: _____________________   Time post onset: ______yrs    _____mos 
Location of stroke:   Left  Right 
Level of Education: 
__________________________________________________________________________  






Passed Hearing Screen:         Yes        No  Score:_____/5 
Passed Vision Screen:                    Yes        No  Score:_____/5 
Testing Date 1: ______ /______ /______ 
Testing Date 2: ______ /______ /______  Time from T1 to T2:_______________ 









Appendix D. (List of Medications) 





Participant 2: Apremilast 
Aspirin 
Duloxetine 









































Participant 7: Alprazolam 
Antidepressants (unspecified) 
Sertraline 
Participant 8: Unavailable 
Participant 9: Unavailable 









Appendix E: (Consent Form) 
RESEARCH CONSENT FORM 
Test Re-test Reliability of the Western Aphasia Battery - Revised 
Susan T Jackson 
(913) 588-5937 
 
You are being invited to join a research study being done at the University of Kansas Medical 
Center (KUMC) by Susan Jackson.  Being in this study is optional.  You can decide not to 
participate or stop at any time.  Regardless of your decision, you will still get the same care from 
your health care team.   
 
Why is this study being done? 
The purpose of this study is to find out whether people with aphasia perform similarly on the 
Western Aphasia Battery-Revised when they are given the test on two different occasions.   
  
What am I being asked to do? 
This study involves two visits to the Hearing and Speech department at the KU Medical Center, 
or we can test you in your home or in a public space (library, place of worship, senior center) if 
you would prefer. Your participation in the study will have two parts:   
 
Part 1 
This part will take about 2 hours. We will begin the study by asking you questions about you and 
about your current health (for example: address, date of birth, date of stroke, handedness, 
medications).  We will test your vision and hearing. You will be given some aphasia tests that 
will include naming objects, repeating words and sentences, answering questions, following 
some directions, reading, writing, drawing some pictures, acting out how to do certain things, 
and choosing the best option to complete a visual design. 
 
Part 2 
This part will take about 1.5. hours.  Part 2 will take place 2-3 weeks after Part 1. You will do the 
same aphasia tests that you did in Part 1 (naming objects, repeating words and sentences, 
answering questions, following some directions, reading, writing, drawing some pictures, acting 
out how to do certain things, and choosing the best option to complete a visual design).  
 
Are there risks or discomforts to consider?   
There are no known risks associated with this study. You may get tired or frustrated, but you 
may take a break at any time or stop the session and continue again on another day. 
 
How will confidentiality and privacy be protected?  
There is a small risk of loss of confidentiality when personal information is used for research.  
Your information will only be used by study team members and approved researchers.  When we 







Appendix E: (Consent Form)-continued 
We will follow the HIPAA laws about privacy.  Study records will include your health 
information and information we collected about you during the research.  We will keep your 
study information indefinitely.  The study information will be kept separately from your name 
and other personal identifiers. Study information will be shared with members of the research 
team.  It might also be seen by people who monitor research if there was an audit.   
 
We will do our best to protect the confidentiality of your information. If study information is 
shared outside KUMC, it will have your name and other direct identifiers removed.  It is possible 
that information shared outside KUMC might be released by others and no longer protected by 
HIPAA laws.  Removing direct identifiers will lessen this risk.     
 
If you want to cancel your permission to use your health information, please write to Susan 
Jackson. The mailing address is: Department of Hearing and Speech, Mailstop 3039, University 
of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160.  If you cancel 
permission to use your health information, we will not gather any new information about you; 
however, we may use and share information that was gathered before we received your 
cancellation.   
 
Consent  
Please talk to the research team if you have any questions about joining the study.  If you have 
questions about the rights of research participants, you may contact the KUMC Institutional 
Review Board at (913) 588-1240 or IRBhelp@kumc.edu.   
 






Printed name:                             
 
 










Appendix F: (Surrogate Consent Form) 
RESEARCH CONSENT FORM-SURROGATE 
Test Re-test Reliability of the Western Aphasia Battery - Revised 
Susan T Jackson 
(913) 588-5937 
 
As a relative or other individual who is making decisions on behalf of a person with aphasia, you 
are being asked to approve his or her participation in a research study being done at the 
University of Kansas Medical Center (KUMC) by Susan Jackson.  Being in this study is 
optional.  The potential participant (the person for whom you are making decisions) does not 
have to participate in this research study. You can decide that you want the potential participant 
to stop being in the study at any time.  Regardless of your decision, the potential participant will 
still get the same care from his or her health care team.   
 
Why is this study being done? 
The purpose of this study is to find out whether people with aphasia perform similarly on the 
Western Aphasia Battery-Revised when they are given the test on two different occasions.   
  
What is the potential participant being asked to do? 
This study involves two visits to the Hearing and Speech department at the KU Medical Center, 
or we can test the potential participant in his or her home or in a public space (library, place of 
worship, senior center) if you would prefer. Participation in the study will have two parts:   
 
Part 1 
This part will take about 2 hours. We will begin the study by asking the potential participant 
questions about him/herself and about his or her current health (for example: address, date of 
birth, date of stroke, handedness, medications).  If the potential participant is not able to answer 
these questions, we will ask you to answer them. We will test the potential participant’s vision 
and hearing. The potential participant will be given some aphasia tests that will include naming 
objects, repeating words and sentences, answering questions, following some directions, reading, 
writing, drawing some pictures, acting out how to do certain things, and choosing the best option 
to complete a visual design. 
 
Part 2 
This part will take about 1.5. hours.  Part 2 will take place 2-3 weeks after Part 1. The potential 
participant will do the same aphasia tests that he or she did in Part 1 (naming objects, repeating 
words and sentences, answering questions, following some directions, reading, writing, drawing 
some pictures, acting out how to do certain things, and choosing the best option to complete a 
visual design).  
 
Are there risks or discomforts to consider?   
There are no known risks associated with this study. The potential participant may get tired or 







Appendix F: (Surrogate Consent Form)-continued 
 
How will confidentiality and privacy be protected?  
There is a small risk of loss of confidentiality when personal information is used for research.  
The potential participant’s information will only be used by study team members and approved 
researchers.  When we write up our results or make presentations, we will not use any names.   
 
We will follow the HIPAA laws about privacy.  Study records will include the potential 
participant’s health information and information we collected about the potential participant 
during the research.  We will keep the potential study participant’s study information 
indefinitely.  The study information will be kept separately from the study participant’s name 
and other personal identifiers. Study information will be shared with members of the research 
team.  It might also be seen by people who monitor research if there was an audit.   
 
We will do our best to protect the confidentiality of the potential participant’s information. If 
study information is shared outside KUMC, it will have the study participant’s name and other 
direct identifiers removed.  It is possible that information shared outside KUMC might be 
released by others and no longer protected by HIPAA laws.  Removing direct identifiers will 
lessen this risk.     
 
If you want to cancel your permission to use the potential participant’s health information, please 
write to Susan Jackson. The mailing address is: Department of Hearing and Speech, Mailstop 
3039, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160.  
If you cancel permission to use the potential participant’s health information, we will not gather 
any new information about the potential participant; however, we may use and share information 
that was gathered before we received your cancellation.   
 
Consent  
Please talk to the research team if you have any questions about the potential participant joining 
the study.  If you have questions about the rights of research participants, you may contact the 
KUMC Institutional Review Board at (913) 588-1240 or IRBhelp@kumc.edu.   
 
If you agree to that you would like the potential participant to join, please sign and date below.  
You will receive a signed copy of this form.   
 
 
Printed name:                             
 
 










Appendix G: (Assent Form) 
ASSENT FORM 
Test Re-test Reliability of the Western Aphasia Battery - Revised 




I have aphasia. I am being asked to be in a research project. 
 
I will be asked to name objects, answer some questions, follow some directions, read some 
words and sentences, and do some other tasks with words. 
 
If I sign my name to the line, it means that I want to be part of the research. I know that I do not 
have to do it and that I can stop being in the research at any time even if I signed. If I want to 
stop, all I have to do is tell a family member, one of the people who take care of me, or the 













Appendix H. (Individual Data) 
Subject 
# 
Age Months post onset Years of 
Education 
Handedness 
1 67 112 13 Right 
2 36 35 18 Right 
3 65 19 12 Left 
4 71 48 18 Right 
5 69 234 21 Right 
6 72 24 21 Right 
7 76 23 12 Right 
8 69 8 18 Right 
9 75 100 16 Right 
10 45 48 19 Right 
Subject 
# 






Male Anomic Anomic 
2 White/Caucasian Female Anomic Anomic 
3 White/Caucasian Male Broca’s Conduction 
4 White/Caucasian Male Broca’s Broca’s 
5 White/Caucasian Male Anomic Anomic 
6 White/Caucasian Male Anomic Anomic 
7 White/Caucasian Male Anomic Conduction 
8 White/Caucasian Male Conduction Conduction 
9 White/Caucasian Male Conduction Conduction 











1 87.00 87.70 76.95 84.40 
2 87.40 87.80 75.80 75.10 
3 73.70 77.90 75.60 75.50 
4 46.10 51.30 45.60 54.30 
5 82.20 82.40 87.00 87.90 
6 87.50 89.00 87.20 84.00 
7 76.70 70.60 63.90 59.70 
8 49.50 43.40 58.90 55.90 
9 65.80 65.90 71.70 64.80 















1 82.25 84.40 18 17 
2 83.10 82.35 17 18 
3 76.75 83.85 12 15 
4 53.55 61.98 9 8 
5 Missing data Missing data 15 15 
6 88.20 87.52 17 17 
7 68.70 65.40 16 13 
8 62.45 57.38 13 13 
9 72.42 70.53 17 16 









1 162 177 90 94 
2 198 186 86 84 
3 191 177 67 66 
4 145 187 40 50 
5 192 190 73 74 
6 181 188 88 90 
7 173 168 70 68 
8 181 142 21 15 
9 158 165 34 32 
10 149 169 50 40 
Subject 
# 
Naming- 1 Naming- 2 Reading-1 Reading-2 
1 84 86 95 90 
2 82 82 56 56 
3 86 85 82 67 
4 28 33 51 64 
5 92 93 100 98 
6 89 91 90 87 
7 67 71 69 66 
8 6 1 72 80 
9 46 55 75 60 










Writing- 1 Writing- 2 Apraxia-1 Apraxia-2 
1 63.5 68.5    55.0  54.0 
2 55.0 53.5 60.0 60.0 
3 64.0 71.5 56.0 56.0 
4 25.5 32.5 54.0 59.0 
5 83.0 88.0 60.0 60.0 
6 82.0 63.5 57.0 58.0 
7 15.5 14.0 54.0 56.0 
8 53.5 55.5 54.0 50.0 
9 79.5 58.0 46.0 53.0 













1 55.0 68.5 9 14 
2 84.0 82.0 5 4 
3 64.5 62.0 10 11 
4 66.00 75.00 6 9 
5 Missing data Missing data 9 11 
6 87.0 89.0 15 16 
7 42.5 44.0 8 8 
8 71.0 67.0 0 0 
9 85.0 87.0 12 6 







    
1 5 8     
2 1 1     
3 2 1     
4 0 4     
5 5 7     
6 7 10     
7 0 0     
8 0 4     
9 0 0     
10 0 0     
 
 
